Deadline: 17-Apr-25
The Pfizer Canada and Colorectal Cancer Canada are collaborating to offer a new funding opportunity seeking proposals for initiatives in either of the two streams, Research or Quality Improvement (QI), focusing on empowering Canadian centres to optimize molecular testing for patients with mCRC.
Streams
- Quality Improvement: Quality improvement (QI) projects are systematic, data-guided, sustainable activities designed to bring about immediate, positive changes in the delivery of healthcare in particular settings. Quality improvement seeks to standardize structure and processes to reduce variation, achieve predictable results, and improve outcomes for patients, healthcare systems, and organizations. Structure includes things like technology, culture, leadership, and physical capital. Process includes knowledge capital (e.g., standard operating procedures) or human capital (e.g., education and training).
- Research: In contrast, research projects use a systematic approach to discover something that is unknown. Research projects add new knowledge to what was previously unknown in literature through testing of a hypothesis or a scientific question4. Research aims to generate knowledge with broad applications, often through controlled studies. The subjects may or may not benefit directly from the knowledge gained. Research studies aim to evaluate an innovation, study something new, or analyze a process not yet rigorously studied.
Funding Opportunities
- The intent of this CFP is to encourage the applicant Canadian organizations and institutions to pursue innovative approaches for Research or QI projects that aim to optimize molecular testing for patients in metastatic CRC at the applicants’ centre. Applicants are invited to implement innovative ideas with the goal of creating a path for sustainable molecular testing for cancer patients in Canada.
- Applicants must submit a Research sa QI project budget for a maximum of C$100,000.
Duration
- Projects should start in 2025 with duration of up to 24 months.
Geographic Scope
- Canada
Eligibility Criteria
- Applicants are strongly encouraged to use a multidisciplinary care model (e.g., pathologist medical oncologist, surgeon, researcher. etc.).
- All partners must have a relevant role, and the requesting organization must have a key role in the project.
- Only organizations are eligible to receive grants, not individuals or medical practice groups.
- The following may apply: medical schools; healthcare institutions (both large and small); professional associations; government agencies; and other entities with a mission related to healthcare improvement.
For more information, visit Pfizer.